Korean researchers have developed an artificial intelligence (AI) model that can accurately predict the prognosis and ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Researchers have validated a specific cluster of microRNAs (miRNAs) as reliable biomarkers for detecting malignant testicular ...

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...

Cellis is preparing to take its lead candidate into the clinic after seeing durable complete remissions in solid-tumor models. Drug developers have struggled to translate the exceptional efficacy ...

The firm previously said it will test the CER T-cell therapy CER-1236 in blood cancers after receiving FDA manufacturing clearance.

The complexity of the TME in vivo limits the conclusions that can be drawn from in vitro models of cancer progression and therapy response. Optimizing cell culture models to mimic the TME is vital to ...

Aptevo Therapeutics (APVO) provided an overview of solid tumor anti-cancer compound APVO603, currently in preclinical development for the ...

Mathematical models for predicting how cancer tumors in mice grow over time can give distorted results if unmeasurable data ...

Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer ...